Nick O'Donnell

A seasoned partner in the London Corporate team, I have over 20 years' experience covering cross-border M&A (public and private), equity capital markets and public company governance including ESG.

My focus is on building long-term relationships with my clients, particularly listed companies, multinationals, international investors and financial advisers. I have spent time on secondment in London with Goldman Sachs, Macquarie and Morgan Stanley. I have strong, current market knowledge and am regularly quoted and interviewed on the markets including on CNBC and Bloomberg and in The Economist, The Daily Telegraph and The Financial Times.

I have a long-track record of successfully executing cross-border deals particularly those involving the UK and Europe and, having previously been based in New York, the US. I also have significant experience of executing Gulf in-bound and out-bound transactions, and was based in Abu Dhabi for two years.

My broad sector experience includes the Technology, Healthcare, Industrials, Energy, Retail, Media and Financial Services sectors, and I enjoy working with our market-leading experts across those areas. Our one firm approach internationally, practical use of technology tools and our desire to build diverse and inclusive teams allows us to provide outstanding and consistent client service on cross-border deals.

My clients trust me to listen, to work collaboratively, to care, to deliver and to invest in their long-term success.

• Board advisory roles to FTSE 250, Standard-listed and AIM-quoted companies, with a particular focus on corporate governance, ESG and shareholder activism issues.
• More than 100 cross-border M&A transactions including acting for: GlaxoSmithKline PLC on the €955 million sale of its travel vaccines Rabipur/Rabavert to Bavarian Nordic and its Verona plant to ACS Dobfar; Hutch Games on its $275 million sale to Nasdaq Nordic listed MTG AB; Cargill on its £1.5 billion acquisition of Provimi and its separate £1.2 billion acquisition of EWOS; Hitachi on its £80 million acquisition of the IA business of Oxford Instruments PLC; Best Buy Inc. on the Class 1 £500 million JV sale transaction with Carphone Warehouse PLC and TBC Bank Group PLC on its acquisition of Bank Republic from Société Générale.
• Multiple takeovers of London-listed companies including acting for: Purecircle Limited on its £185 million takeover by Ingredion, Inc.; The Olayan Group on the possible £2.9 billion consortium offer for intu Properties PLC; Vermeg Group NV on its recommended cash offer for Lombard Risk Management PLC; Worldview on its deal for Petroceltic International PLC and Exillion Energy PLC on its formal sale process under the UK Takeover Code.
• More than 50 successful European, US and Gulf IPOs, capital raisings, returns of capital, demergers, delistings, block trades and redomestications including acting for: FTSE 250 member TBC Bank Group PLC's $640 million IPO and subsequent Premium Listing; former FTSE 250 member Collins Stewart Tullett PLC on its demerger; Management Consulting Group PLC on its $165 million disposal of Kurt Salmon to Accenture and subsequent return of capital to shareholders; Rowan Companies, Inc. on its $4 billion inversion to the UK by way of triangular merger; Bologna Airport and Massimo Zanetti on the English law aspects of their respective IPOs on the Italian Stock Exchange and Palm Hills Development SAE on its delisting in London.